Wennuan Liu
Overview
Explore the profile of Wennuan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
3354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu W, Zheng S, Na R, Wei L, Sun J, Gallagher J, et al.
Mol Cancer Res
. 2020 Oct;
18(12):1815-1824.
PMID: 33115829
We aim to understand, from acquired genetic alterations in tumors, why African American (AA) men are more likely to develop aggressive prostate cancer. By analyzing somatic mutations in 39 genes...
2.
Liu W, Hou J, Petkewicz J, Na R, Wang C, Sun J, et al.
Prostate
. 2020 Aug;
80(14):1253-1262.
PMID: 32803894
Background: To assess the feasibility of a novel DNA-based probe panel to detect copy number alterations (CNAs) in prostate tumor DNA and its performance for predicting clinical progression. Methods: A...
3.
Callahan Z, Liu W, Hou J, Zheng S, Rehman J, Hedberg H, et al.
Surg Endosc
. 2020 Aug;
35(7):3961-3970.
PMID: 32749611
Background: The purpose of this study was to analyze non-dysplastic Barrett's esophagus (NDBE) biopsy tissue and compare the rate of somatic DNA copy number alterations (CNAs) in patients who subsequently...
4.
Zhang N, Chen S, Jiang G, Wu Y, Shao J, Liu W, et al.
J Cancer
. 2020 Jan;
11(1):16-24.
PMID: 31892969
Copy number alteration (CNA) is one of the important genetic variations. Although there are many studies on renal cancer CNA, few studies are based on the Chinese population. In our...
5.
Wang J, Zhang X, Shi J, Cao P, Wan M, Zhang Q, et al.
Oncotarget
. 2016 Oct;
7(48):78566-78576.
PMID: 27713175
Fatty acid synthase (FASN) is upregulated in breast cancer and correlates with poor prognosis. FASN contributes to mammary oncogenesis and serves as a bona fide target in cancer therapies. MicroRNAs...
6.
7.
Liu W
Asian J Androl
. 2016 Mar;
18(4):533-42.
PMID: 26975494
Although most prostate cancer (PCa) cases are not life-threatening, approximately 293 000 men worldwide die annually due to PCa. These lethal cases are thought to be caused by coordinated genomic...
8.
Holmes J, Paulsson A, Page B, Miller L, Liu W, Xu J, et al.
J Neurooncol
. 2015 Jul;
124(3):447-53.
PMID: 26186902
We present a retrospective investigation of the role of genomics in the prediction of central versus marginal disease progression patterns for glioblastoma (GBM). Between August 2000 and May 2010, 41...
9.
Chen H, Yu H, Wang J, Zhang Z, Gao Z, Chen Z, et al.
Prostate
. 2015 May;
75(12):1264-76.
PMID: 26015065
Background: More than 100 prostate cancer (PCa) risk-associated single nucleotide polymorphisms (SNPs) have been identified by genome wide association studies (GWAS). However, the molecular mechanisms are unclear for most of...
10.
Rodrigues L, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, et al.
Cancer Res
. 2015 Mar;
75(6):1021-34.
PMID: 25770290
Prostate cancer subtypes are poorly defined and functional validation of drivers of ETS rearrangement-negative prostate cancer has not been conducted. Here, we identified an ETS(-) subtype of aggressive prostate cancer...